Sunshine Biopharma (SBFM) Gains from Investment Securities (2016 - 2024)
Sunshine Biopharma (SBFM) reported Gains from Investment Securities of -$373529.0 for Q4 2024, down 139.07% quarter-over-quarter from $956012.0 in Q1 2024.
Sunshine Biopharma (SBFM) Gains from Investment Securities (2016 - 2024) Analysis & Trends
Sunshine Biopharma has reported Gains from Investment Securities for 5 years, with the latest figure at -$373529.0 in Q4 2024.
- For the quarter ending Q4 2024, Gains from Investment Securities changed N/A year-over-year to -$373529.0; the trailing twelve-month figure through Sep 2025 stood at -$373529.0 (down 139.07% YoY), and the FY2024 full-year result was $582483.0, changed N/A from the prior year.
- Gains from Investment Securities for Q4 2024 stood at -$373529.0, down from $956012.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $956012.0 in Q1 2024, with the low at -$373529.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Sunshine Biopharma | 10.94 Mn | 4.03 Mn | 2.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -373,529.00 |
| Dec 31, 2024 | -373,529.00 |
| Mar 31, 2024 | 956,012.00 |
| Mar 31, 2024 | 956,012.00 |
| Sep 30, 2020 | -8,002.00 |
| Sep 30, 2020 | -8,002.00 |
| Jun 30, 2020 | 8,002.00 |
| Jun 30, 2020 | 8,002.00 |
| Sep 30, 2018 | -484,100.00 |
| Sep 30, 2018 | -484,100.00 |
| Jun 30, 2018 | 484,100.00 |
| Jun 30, 2018 | 484,100.00 |
| Sep 30, 2017 | 349,000.00 |
| Sep 30, 2017 | 349,000.00 |
| Jun 30, 2017 | 64,000.00 |
| Jun 30, 2017 | 64,000.00 |
| Sep 30, 2016 | 67,500.00 |
| Sep 30, 2016 | 67,500.00 |